Pregabalin
ApprovedWithdrawn 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Low Back Pain
Conditions
Low Back Pain, Neuralgia
Trial Timeline
Feb 1, 2012 → Feb 1, 2013
NCT ID
NCT01298466About Pregabalin
Pregabalin is a approved stage product being developed by Pfizer for Low Back Pain. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01298466. Target conditions include Low Back Pain, Neuralgia.
What happened to similar drugs?
8 of 20 similar drugs in Low Back Pain were approved
Approved (8) Terminated (2) Active (12)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (20)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01773993 | Pre-clinical | Completed |
| NCT01603394 | Approved | Terminated |
| NCT01463306 | Phase 3 | Completed |
| NCT01298466 | Approved | Withdrawn |
| NCT01474772 | Phase 3 | Completed |
| NCT01397006 | Approved | Withdrawn |
| NCT01020526 | Approved | Completed |
| NCT01202227 | Phase 3 | Completed |
| NCT01226667 | Approved | Completed |
| NCT00819988 | Phase 3 | Completed |
| NCT00596466 | Phase 3 | Completed |
| NCT00553280 | Phase 3 | Completed |
| NCT01061697 | Approved | Completed |
| NCT00891397 | Pre-clinical | Terminated |
| NCT00448916 | Phase 3 | Completed |
| NCT00407797 | Approved | Terminated |
| NCT00424372 | Phase 3 | Completed |
| NCT00407511 | Approved | Completed |
| NCT00346034 | Phase 3 | Completed |
| NCT00843284 | Pre-clinical | Completed |
Competing Products
20 competing products in Low Back Pain